Bellerophon Therapeutics, Inc. (BLPH) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 8.6M |
| Enterprise Value | 1.87M |
| P/E Ratio | -0.01 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.05 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.3 |
| Fiscal Year | December 31, 2022 |
| Most Recent Quarter | September 30, 2023 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -2.5 |
| Return On Equity | -1.64 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -65,000 |
| EBITDA | -22.18M |
| Net Income | -19.83M |
| Diluted EPS | -2.08 |
| Total Cash | 4.38M |
| Total Cash/Share | 0.77 |
| Total Debt | 0 |
| Total Debt/Equity | 0.08 |
| Current Ratio | 1.4 |
| Book Value Per Share | 0.27 |
| 52-Week Change | -81.27 |
| 52-Week High | 0.1 |
| 52-Week Low | 0.01 |
| Moving Average 50 Days | 0.04 |
| Moving Average 200 Days | 0.05 |
| Average Volume | 13,687 |
| Shares Outstanding | 12.23M |
| % Held by Institutions | 1.71 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | February 10, 2020 |